Amphastar 制药 AMPH
$28.49 +$0.83 (+3.00%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.49 0.00%
开盘$29.44
昨收$27.66
当日区间$27.80 – $31.00
成交量826.3K
市值$1.22B
市盈率（TTM）13.1
股息率–
财报
财报日平均波动±10.6%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+15.4%
最差反应-23.6%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | – | +4.90% | – |
| 2026/Q1 | 7 May 2026 | After Market | ±16.3% | -20.93% | 超出定价预期 |
| 2025/Q4 | 26 Feb 2026 | After Market | ±11.9% | -23.63% | 超出定价预期 |
| 2025/Q3 | 6 Nov 2025 | After Market | – | -0.83% | – |
| 2025/Q2 | 7 Aug 2025 | After Market | ±12.0% | +10.13% | 符合区间 |
| 2025/Q1 | 7 May 2025 | After Market | ±19.5% | +0.90% | 符合区间 |
| 2024/Q4 | 27 Feb 2025 | After Market | ±12.4% | -9.72% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±10.3% | -13.69% | 超出定价预期 |
| 2024/Q2 | 7 Aug 2024 | After Market | ±16.6% | +13.29% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±14.5% | +0.52% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±15.2% | -14.93% | 符合区间 |
| 2023/Q3 | 8 Nov 2023 | After Market | ±12.2% | +15.39% | 超出定价预期 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±13.4% | -4.29% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±9.2% | +13.04% | 超出定价预期 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±17.5% | +14.75% | 符合区间 |
| 2022/Q3 | 7 Nov 2022 | After Market | ±14.0% | -9.37% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$183.90M+5.4% YoY
营业利润$39.73M-5.8% YoY
净利润$30.35M-2.2% YoY
摊薄每股收益$0.67+4.7% YoY
自由现金流$42.73M+87.6% YoY
经营现金流$51.32M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率47.7%
营业利润率15.7%
净利率10.8%
净资产收益率10.3%
资产收益率4.7%
投入资本回报率6.4%
流动比率2.40
负债/资产比率55.9%
现金及投资$290.12M
总负债$679.52M
净现金（净负债）-$389.40M
自由现金流/营收20.9%
暂无评论——快来第一个聊聊 AMPH。